IFM Therapeutics Receives $27,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    IFM Therapeutics
  • Mailing Address
    400 Technology Square 10th Floor Cambridge, MA 02139 USA
  • Company Description
    At IFM Therapeutics, we are driven to invent transformative therapies to improve the lives of patients with serious, life threatening diseases. We are passionate about building a company that embraces creativity, integrity, and excellence.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the proceeds of the financing to advance and expand its early-stage portfolio and begin clinical development of its most advanced product candidate, a selective activator of a novel target, for treating solid tumors.
  • M&A Terms
  • Venture Investor
    Atlas Accelerator
  • Venture Investor
  • Venture Investor
    Novartis Venture Fund

Trending on Xconomy